Marinus Pharmaceuticals Inc (MRNS)
1.455
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
1.455
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Total Long Term Debt (Quarterly): 72.97M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 72.97M |
| September 30, 2023 | 72.48M |
| June 30, 2023 | 71.99M |
| March 31, 2023 | 72.82M |
| December 31, 2022 | 71.02M |
| September 30, 2022 | 70.78M |
| June 30, 2022 | 70.35M |
| Date | Value |
|---|---|
| March 31, 2022 | 69.93M |
| December 31, 2021 | 40.81M |
| September 30, 2021 | 40.58M |
| June 30, 2021 | 10.97M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2020
72.97M
Maximum
Dec 2023
47.48M
Average
70.14M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 0.00 |
| Soligenix Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | 0.00 |
| ADMA Biologics Inc | 130.59M |